Back to search
FDAFDA · Food and drugs·Recall number D-0608-2022

Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY: RITE AID, 30 HUNTER LANE, CAMP HILL, PA 17011. NDC 11822-6378-1

Published March 2, 2022 · Recall initiated: October 26, 2021

Summary

FDA records drug Class II recall D-0608-2022, published March 2, 2022 and initiated October 26, 2021. Recalling firm: Perrigo Company PLC; Status: Terminated; Reported quantity: 9,888 bottles; Lot: Batch: 11BK0827, Exp 12/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

What to do

Voluntary: Firm initiated · Letter

Get an email if NASAL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NASAL
Manufacturer
Perrigo Company PLC
Distributor
Nationwide in the USA
Lot
Batch: 11BK0827, Exp 12/31/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY: RITE AID, 30 HUNTER LANE, CAMP HILL, PA 17011. NDC 11822-6378-1 recalled?

Yes. FDA published recall D-0608-2022 on March 2, 2022. Reported hazard: CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NASAL.